Alpaca nanobodies effective against South African SARS-CoV-2 variant
Alpaca nanobodies effective against South African SARS-CoV-2 variant Researchers in South Africa and the UK have identified alpaca-derived nanoantibodies that potently neutralize variants of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19). Notably, one of the nanoantibodies neutralized the South African variant of concern B.1.351 that has been shown to reduce the effectiveness of vaccines against the virus. “Therapeutic options that work against the B.1.351 variant are urgently needed to counteract reduced ...
Source: news-medical.net